|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.24 DKK | -1.05% |
|
+0.05% | +0.19% |
| 15/06 | H. Lundbeck A/S Presents Preliminary Phase II Part A Data for Asedebart in Cushing's Disease | CI |
| 05/06 | H. Lundbeck A/S - Special Call |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 47.21 | +8.03% | 12 | |||||||
| 941.4 | +20.07% | 15 | |||||||
| 245.27 | +9.57% | 15 | |||||||
| 3.333 | +26.26% | 15 | |||||||
| 20.56 | +25.83% | 8 | |||||||
| 47.12 | +61.86% | 9 | |||||||
| 19.97 | +34.59% | 13 | |||||||
| 87.2 | +2.65% | 5 | |||||||
| 5.935 | +23.9% | 4 | |||||||
| 2,912.5 | +10.41% | 4 | |||||||
| - | 36.43 | +30.81% | 2 | ||||||
| 25.84 | +48.71% | 8 | |||||||
| 6,466.67 | +27.95% | 3 | |||||||
| 27.19 | +20.05% | 5 | |||||||
| - | - | 4,525 | +11.07% | 2 | |||||
| - | 27.31 | +34.07% | 1 | ||||||
| 129.04 | +15% | 4 | |||||||
| 5.338 | +8.49% | 8 | |||||||
| Average | 865.18 | +23.30% | 7 | ||||||
| Weighted average by Cap. | 594.54 | +19.89% | 13 |
- Stock Market
- Stocks
- HLUN B Stock
- Sector H. Lundbeck A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















